A trial of oral azacitidine for acute myeloid leukaemia that has completely disappeared after chemotherapy (QUAZAR AML-001)

Overview

Cancer types:

Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia

Status:

Results

Phase:

Phase 3

Details

This trial looked azacitidine tablets and best supportive care for acute myeloid leukaemia that was in remission. This means people had no signs of leukaemia after initial treatment.

The trial was open for people to join between 2013 and 2017. The team published the results in 2020. There is a link to more information in the ‘Summary of results’ section below.

Recruitment start: 1 May 2013

Recruitment end: 31 May 2017